Skip to main content
EQT Logo

Grantee

Rhian Stavely

Autologous enteric neural stem cells for Hirschsprung disease

Hirschsprung disease is caused by the absence of enteric neurons, leading to severe bowel dysfunction despite lifesaving surgery. This project develops an autologous enteric neural stem cell therapy that replaces missing neurons using a patient’s own cells. By rebuilding functional enteric neural networks, the approach aims to restore gut motility and reduce lifelong complications. The work focuses on defining potency, manufacturing scalability, and safety to enable first-in-human clinical translation.

Key Facts
Country

United States

University

MGH & Harvard Medical School

Year

2026

Do you want to know more about investing with EQT?

Get in touch with us and take the first step to successive growth.